<div class="container">

<table style="width: 100%;"><tr>
<td>power.tsd.fC</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>
Power calculation of adaptive 2-stage BE studies (2x2 crossover) with a
futility criterion for the point estimate of T/R or its 90% CI
</h2>

<h3>Description</h3>

<p>This function calculates the ‘empiric’ power of 2-stage BE studies according
to Potvin <em>et al.</em> ‘method B/C’ via simulations. The Potvin methods are
modified to include a futility criterion for the point estimate or for its
90%CI and to allow the sample size estimation step to be done with the point
estimate (<abbr><span class="acronym">PE</span></abbr>) and <abbr><span class="acronym">MSE</span></abbr> of stage 1.
</p>


<h3>Usage</h3>

<pre><code class="language-R">power.tsd.fC(method = c("B", "C", "B0"), alpha0 = 0.05, alpha = c(0.0294, 0.0294),
             n1, CV, GMR, targetpower = 0.8, pmethod = c("nct", "exact", "shifted"),
             usePE = FALSE, powerstep = TRUE, min.n2=0, max.n=Inf,
             fCrit=c("CI", "PE"), fClower, fCupper, theta0, theta1, theta2,
             npct = c(0.05, 0.5, 0.95), nsims, setseed = TRUE, details = FALSE)
</code></pre>


<h3>Arguments</h3>

<table>
<tr style="vertical-align: top;">
<td><code>method</code></td>
<td>

<p>Decision schemes according to Potvin <em>et.al.</em> (defaults to <code style="white-space: pre;">⁠"B"⁠</code>).<br>
Montague’s ‘Method D’ can be obtained by choosing <code style="white-space: pre;">⁠"C"⁠</code> but setting
<code style="white-space: pre;">⁠alpha=c(0.028, 0.028)⁠</code>.<br>
‘Method E’ of Xu <em>et al.</em> can be obtained by choosing <code style="white-space: pre;">⁠"B"⁠</code> and setting alphas,
futility criterion <code style="white-space: pre;">⁠"CI"⁠</code>, <code style="white-space: pre;">⁠max.n⁠</code>, and <code style="white-space: pre;">⁠n1⁠</code> according to the reference.<br>
‘Method F’ can be obtained choosing <code style="white-space: pre;">⁠"C"⁠</code> with the appropriate design setting
according to the reference.<br><code style="white-space: pre;">⁠method="B0"⁠</code> uses the decision scheme of Zheng <em>et al.</em> <abbr><span class="acronym">MSDBE</span></abbr>
(modified sequential design for <abbr><span class="acronym">B</span></abbr>E studies) which differs from B in case
of different alphas w.r.t. power monitoring and BE decision in case of power
&gt;= target power.
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>alpha0</code></td>
<td>

<p>Alpha value for the first step(s) in Potvin <code style="white-space: pre;">⁠"C"⁠</code>, the power inspection
and BE decision if power &gt; targetpower. Defaults to 0.05.<br>
Only observed if <code style="white-space: pre;">⁠method="C"⁠</code>
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>alpha</code></td>
<td>

<p>Vector (two elements) of the nominal alphas for the two stages. Defaults to
Pocock’s setting <code style="white-space: pre;">⁠alpha=c(0.0294, 0.0294)⁠</code>.<br>
Common values together with other arguments are:<br><code style="white-space: pre;">⁠rep(0.0294, 2)⁠</code>: Potvin <em>et al.</em> ‘Method B’ <code style="white-space: pre;">⁠(fCrit="CI", fCupper=Inf)⁠</code><br><code style="white-space: pre;">⁠rep(0.0269, 2)⁠</code>: Fulgsang ‘Method C/D’ <code style="white-space: pre;">⁠(method="C", GMR=0.9, targetpower=0.9, fCrit="CI", fCupper=Inf)⁠</code><br><code style="white-space: pre;">⁠rep(0.0274, 2)⁠</code>: Fuglsang ‘Method C/D’ <code style="white-space: pre;">⁠(method="C", targetpower=0.9, fCrit="CI", fCupper=Inf)⁠</code><br><code style="white-space: pre;">⁠rep(0.0280, 2)⁠</code>: Montague <em>et al.</em> ‘Method D’ <code style="white-space: pre;">⁠(method="C", GMR=0.9, fCrit="CI", fCupper=Inf)⁠</code><br><code style="white-space: pre;">⁠rep(0.0284, 2)⁠</code>: Fulgsang ‘Method B’ <code style="white-space: pre;">⁠(GMR=0.9, targetpower=0.9, fCrit="CI", fCupper=Inf)⁠</code><br><code style="white-space: pre;">⁠rep(0.0304, 2)⁠</code>: Kieser &amp; Rauch <code style="white-space: pre;">⁠(fCrit="CI", fCupper=Inf)⁠</code><br><code style="white-space: pre;">⁠c(0.01, 0.04)⁠</code>: Zheng <em>et al.</em> ‘MSDBE’ <code style="white-space: pre;">⁠(method="B0", fCrit="CI", fCupper=Inf)⁠</code><br><code style="white-space: pre;">⁠c(0.0249, 0.0357)⁠</code>: Xu <em>et al.</em> ‘Method E’ for CV 10–30% <code style="white-space: pre;">⁠(fCrit="CI", fClower=0.9374, max.n=42)⁠</code><br><code style="white-space: pre;">⁠c(0.0254, 0.0363)⁠</code>: Xu <em>et al.</em> ‘Method E’ for CV 30–55% <code style="white-space: pre;">⁠(fCrit="CI", fClower=0.9305, max.n=42)⁠</code><br><code style="white-space: pre;">⁠c(0.0248, 0.0364)⁠</code>: Xu <em>et al.</em> ‘Method F’ for CV 10–30% <code style="white-space: pre;">⁠(method="C", fCrit="CI", fClower=0.9492, max.n=180)⁠</code><br><code style="white-space: pre;">⁠c(0.0259, 0.0349)⁠</code>: Xu <em>et al.</em> ‘Method F’ for CV 30–55% <code style="white-space: pre;">⁠(method="C", fCrit="CI", fClower=0.9350, max.n=180)⁠</code>
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>n1</code></td>
<td>

<p>Sample size of stage 1. For Xu’s
methods the recommended sample size should be at least 18 (if CV 10–30%) or
48 (if CV 30–55%).
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>CV</code></td>
<td>

<p>Coefficient of variation of the intra-subject variability
(use <em>e.g.</em>, 0.3 for 30%).
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>GMR</code></td>
<td>

<p>Ratio T/R to be used in decision scheme (power calculations in
stage 1 and sample size estimation for
stage 2).
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>targetpower</code></td>
<td>

<p>Power threshold in the power monitoring steps and
power to achieve in the sample size estimation step.
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>pmethod</code></td>
<td>

<p>Power calculation method, also to be used in the sample size estimation for
stage 2.<br>
Implemented are <code style="white-space: pre;">⁠"nct"⁠</code> (approximate calculations via non-central
<em>t</em>-distribution, <code style="white-space: pre;">⁠"exact"⁠</code> (exact calculations via Owen’s Q),
and <code style="white-space: pre;">⁠"shifted"⁠</code> (approximate calculation via shifted central <em>t</em>-distribution
like in the paper of Potvin <em>et al.</em><br>
Defaults to <code style="white-space: pre;">⁠"nct"⁠</code> as a reasonable compromise between speed and
accuracy in the sample size estimation step.
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>usePE</code></td>
<td>

<p>If <code style="white-space: pre;">⁠TRUE⁠</code> the sample size estimation step is done with <abbr><span class="acronym">MSE</span></abbr>
<b>and</b> PE of stage 1.<br>
Defaults to <code style="white-space: pre;">⁠FALSE⁠</code>, <em>i.e.</em>, the sample size is estimated with anticipated
(fixed) <code style="white-space: pre;">⁠GMR⁠</code> given as argument and <abbr><span class="acronym">MSE</span></abbr> of
stage 1 (analogous to Potvin <em>et. al.</em>).
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>powerstep</code></td>
<td>

<p>If <code style="white-space: pre;">⁠TRUE⁠</code> (the default) the interim power monitoring step in
stage 1 evaluation of ‘method B’
will be done as described in Potvin <em>et.al.</em><br>
Setting this argument to <code style="white-space: pre;">⁠FALSE⁠</code> will omit this step.<br>
Has no effect if <code style="white-space: pre;">⁠method="C"⁠</code> is choosen.
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>min.n2</code></td>
<td>

<p>Minimum sample size of stage 2. Defaults to zero.<br>
If the sample size estimation step gives <code style="white-space: pre;">⁠N &lt; n1+min.n2⁠</code> the sample size for
stage 2 will be forced to <code style="white-space: pre;">⁠min.n2⁠</code>,
<em>i.e.</em>, the total sample size to <code>n1+min.n2</code>.
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>max.n</code></td>
<td>

<p>If <code style="white-space: pre;">⁠max.n⁠</code> is set to a finite value the re-estimated total sample size (N) is
set to <code>min(max.n, N)</code>.<br>
Defaults to <code style="white-space: pre;">⁠Inf⁠</code> which is equivalent to not constrain the re-estimated sample size.<br>
Attention! <code style="white-space: pre;">⁠max.n⁠</code> here is <b>not</b> a futility criterion like <code style="white-space: pre;">⁠Nmax⁠</code>
in other functions of this package.
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>fCrit</code></td>
<td>

<p>Futility criterion.<br>
If set to <code style="white-space: pre;">⁠"PE"⁠</code> the study stops after
stage 1 if not <abbr><span class="acronym">BE</span></abbr> and if the point
estimate (<abbr><span class="acronym">PE</span></abbr>) of stage 1 evaluation
is outside the range defined in the next two  arguments <code style="white-space: pre;">⁠"fClower"⁠</code> and
<code style="white-space: pre;">⁠"fCupper"⁠</code>.<br>
If set to <code style="white-space: pre;">⁠"CI"⁠</code> the study stops after stage 1
if not <abbr><span class="acronym">BE</span></abbr> and if the confidence interval of
stage 1 evaluation is outside the range
defined in the next two arguments.<br>
Defaults to <code style="white-space: pre;">⁠"PE"⁠</code>.
Futility criterion to use for <code style="white-space: pre;">⁠PE⁠</code> or <code style="white-space: pre;">⁠CI⁠</code>.
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>fClower</code></td>
<td>

<p>Lower futility limit for the <code style="white-space: pre;">⁠PE⁠</code> or <code style="white-space: pre;">⁠CI⁠</code> of
stage 1.<br>
If the <code style="white-space: pre;">⁠PE⁠</code> or <code style="white-space: pre;">⁠CI⁠</code> is outside <code style="white-space: pre;">⁠fClower⁠</code> ... <code style="white-space: pre;">⁠fCupper⁠</code>
the study is stopped in the interim with the result FAIL (not BE).<br>
May be missing. Defaults then to 0.8 if <code style="white-space: pre;">⁠fCrit="PE"⁠</code> or 0.925 if
<code style="white-space: pre;">⁠fCrit="CI"⁠</code>.
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>fCupper</code></td>
<td>

<p>Upper futility limit for the <code style="white-space: pre;">⁠PE⁠</code> or <code style="white-space: pre;">⁠CI⁠</code> of
stage 1.<br>
Will be set to <code style="white-space: pre;">⁠1/fClower⁠</code> if missing.
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>theta0</code></td>
<td>

<p>Assumed ratio of geometric means (T/R) for simulations. If missing,
defaults to <code style="white-space: pre;">⁠GMR⁠</code>.
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>theta1</code></td>
<td>

<p>Lower bioequivalence limit. Defaults to 0.8.
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>theta2</code></td>
<td>

<p>Upper bioequivalence limit. Defaults to 1.25.
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>npct</code></td>
<td>

<p>Percentiles to be used for the presentation of the distribution of
<code style="white-space: pre;">⁠n(total)=n1+n2⁠</code>.<br>
Defaults to <code style="white-space: pre;">⁠c(0.05, 0.5, 0.95)⁠</code> to obtain the 5% and 95% percentiles
and the median.
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>nsims</code></td>
<td>

<p>Number of studies to simulate.<br>
If missing, <code style="white-space: pre;">⁠nsims⁠</code> is set to 1E+05 = 100,000 or to 1E+06 = 1 Mio if
estimating the empiric Type I Error (<code style="white-space: pre;">⁠'alpha'⁠</code>), <em>i.e.</em>, with <code style="white-space: pre;">⁠theta0⁠</code> at
the border or outside the acceptance range <code style="white-space: pre;">⁠theta1⁠</code> ... <code style="white-space: pre;">⁠theta2⁠</code>.
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>setseed</code></td>
<td>

<p>Simulations are dependent on the starting point of the (pseudo) random number
generator. To avoid differences in power for different runs a
<code>set.seed(1234567)</code> is issued if <code style="white-space: pre;">⁠setseed=TRUE⁠</code>, the default.<br>
Set this argument to <code style="white-space: pre;">⁠FALSE⁠</code> to view the variation in power between
different runs.
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>details</code></td>
<td>

<p>If set to <code style="white-space: pre;">⁠TRUE⁠</code> the function prints the results of time measurements
of the simulation steps. Defaults to <code style="white-space: pre;">⁠FALSE⁠</code>.
</p>
</td>
</tr>
</table>
<h3>Details</h3>

<p>The calculations follow in principle the simulations as described in Potvin
<em>et al</em>.<br>
The underlying subject data are assumed to be evaluated after log-transformation.
But instead of simulating subject data, the statistics pe1, mse1 and pe2, SS2 are
simulated via their associated distributions (normal and
χ<sup>2</sup> distributions).
</p>


<h3>Value</h3>

<p>Returns an object of class <code style="white-space: pre;">⁠"pwrtsd"⁠</code> with all the input arguments and results
as components.<br>
The class <code style="white-space: pre;">⁠"pwrtsd"⁠</code> has an S3 print method.<br>
The results are in the components:
</p>
<table>
<tr style="vertical-align: top;">
<td><code>pBE</code></td>
<td>
<p>Fraction of studies found BE.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>pBE_s1</code></td>
<td>
<p>Fraction of studies found BE in stage 1.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>pct_s2</code></td>
<td>
<p>Percentage of studies continuing to stage 2.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>nmean</code></td>
<td>
<p>Mean of n(total), aka average total sample size (<abbr><span class="acronym">ASN</span></abbr>).</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>nrange</code></td>
<td>
<p>Range (min, max) of n(total).</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>nperc</code></td>
<td>
<p>Percentiles of the distribution of n(total).</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>ntable</code></td>
<td>
<p>Object of class <code style="white-space: pre;">⁠"table"⁠</code> summarizing the discrete distribution of
n(total) via its distinct values and counts of occurences of these values.<br>
This component is only given back if <code>usePE==FALSE</code> or
<code>usePE==TRUE &amp; fClower&gt;0 &amp; is.finite(fCupper)</code>, <em>i.e.</em>, a futility range is used.</p>
</td>
</tr>
</table>
<h3>Author(s)</h3>

<p>D. Labes
</p>


<h3>References</h3>

<p>Potvin D, DiLiberti CE, Hauck WW, Parr AF, Schuirmann DJ, Smith RA. <em>Sequential design approaches for bioequivalence studies with crossover designs.</em><br>
Pharm Stat. 2008; 7(4):245–62. doi: <a href="https://doi.org/10.1002/pst.294">10.1002/pst.294</a>
</p>
<p>Montague TH, Potvin D, DiLiberti CE, Hauck WW, Parr AF, Schuirmann DJ. <em>Additional results for ‘Sequential design approaches for bioequivalence studies with crossover designs’.</em><br>
Pharm Stat. 2011; 11(1):8–13. doi: <a href="https://doi.org/10.1002/pst.483">10.1002/pst.483</a>
</p>
<p>Fuglsang A. <em>Sequential Bioequivalence Trial Designs with Increased Power and
Controlled Type I Error Rates.</em><br>
AAPS J. 2013; 15(3):659–61. doi: <a href="https://doi.org/10.1208/s12248-013-9475-5">10.1208/s12248-013-9475-5</a>
</p>
<p>Schütz H. <em>Two-stage designs in bioequivalence trials.</em><br>
Eur J Clin Pharmacol. 2015; 71(3):271–81. doi: <a href="https://doi.org/10.1007/s00228-015-1806-2">10.1007/s00228-015-1806-2</a>
</p>
<p>Kieser M, Rauch G. <em>Two-stage designs for cross-over bioequivalence trials.</em><br>
Stat Med. 2015; 34(16):2403–16. doi: <a href="https://doi.org/10.1002/sim.6487">10.1002/sim.6487</a>
</p>
<p>Zheng Ch, Zhao L, Wang J. <em>Modifications of sequential designs in bioequivalence trials.</em><br>
Pharm Stat. 2015; 14(3):180–8. doi: <a href="https://doi.org/10.1002/pst.1672">10.1002/pst.1672</a>
</p>
<p>Xu J, Audet C, DiLiberti CE, Hauck WW, Montague TH, Parr TH, Potvin D, Schuirmann DJ.
<em>Optimal adaptive sequential designs for crossover bioequivalence studies.</em><br>
Pharm Stat. 2016;15(1):15–27. doi: <a href="https://doi.org/10.1002/pst.1721">10.1002/pst.1721</a>
</p>


<h3>See Also</h3>

<p><code>power.tsd</code>
</p>


<h3>Examples</h3>

<pre><code class="language-R"># using all the defaults
power.tsd.fC(CV=0.25, n1=24)
# run-time ~1 sec
## Not run: 
# as above but storing the results
res &lt;- power.tsd.fC(CV=0.25, n1=24)
# representation of the discrete distribution of n(total)
# via plot method of object with class "table" which creates a
# 'needle' plot
plot(res$ntable/sum(res$ntable), ylab="Density",
     xlab=expression("n"[total]), las=1,
     main=expression("Distribution of n"[total]))
## End(Not run)
</code></pre>


</div>